diff --git a/What-Does-Parental-Control-Do%3F.md b/What-Does-Parental-Control-Do%3F.md
new file mode 100644
index 0000000..b3b6fd7
--- /dev/null
+++ b/What-Does-Parental-Control-Do%3F.md
@@ -0,0 +1,88 @@
+Introduction
+
+Childhood vaccines have played a pivotal role in public health since their inception, leading to the prevention and near-eradication of several infectious diseases that once claimed countless lives. This report delves into the history, development, types, and effectiveness of childhood vaccines, as well as addressing common misconceptions and the importance of vaccination in maintaining herd immunity.
+
+Historical Background
+
+The concept of vaccination dates back to the late 18th century. Edward Jenner is credited with developing the first successful smallpox vaccine in 1796. Jenner observed that milkmaids who had contracted cowpox appeared to be immune to smallpox. By inoculating an 8-year-old boy with cowpox, he established the principle of vaccination. This led to the eventual global eradication of smallpox by 1980.
+
+Development of Childhood Vaccines
+
+The development of vaccines has evolved significantly over the years. The process generally involves several stages:
+
+Research and Discovery: Scientists identify the pathogen responsible for the disease and determine which parts of it can stimulate an immune response.
+
+Preclinical Testing: Before testing on humans, the vaccine is tested in laboratory settings and on animals to assess its safety and the immune response it generates.
+
+Clinical Trials:  [Toddler nutrition](http://bbs.hk-taxi.com/uhome/link.php?url=https://keramika-tula.ru/user/santonqtew) These are conducted in phases:
+- Phase I evaluates safety and dosage in a small group of healthy volunteers.
+- Phase II assesses effectiveness and further examines safety in a larger group.
+- Phase III involves tens of thousands of participants to establish efficacy and monitor adverse reactions.
+
+Regulatory Approval: After successful trials, manufacturers submit data to regulatory bodies like the Food and Drug Administration (FDA) in the U.S. for approval.
+
+Post-Market Surveillance: After approval, the vaccine is monitored for long-term effects and effectiveness in the general population.
+
+Types of Childhood Vaccines
+
+Childhood vaccines can be categorized into several groups based on the type of immune response they elicit: 
+
+Live Attenuated Vaccines: These contain weakened forms of the virus or bacteria, allowing the body to mount a strong immune response. Examples include the measles, mumps, and rubella (MMR) vaccine and the varicella (chickenpox) vaccine.
+
+Inactivated or Killed Vaccines: These contain pathogens that have been killed or inactivated. They are generally safer but may require booster shots for sustained immunity. Examples are the polio vaccine and the hepatitis A vaccine.
+
+Subunit, Recombinant, and Conjugate Vaccines: These contain only parts of the pathogen (subunits) or are combined with a carrier protein to boost the immune response (conjugate vaccines). The Haemophilus influenzae type b (Hib) vaccine and the human papillomavirus (HPV) vaccine fall into this category.
+
+Messenger RNA (mRNA) Vaccines: A newer technology employed in vaccines such as those for COVID-19 (e.g., Pfizer-BioNTech and Moderna). These vaccines use synthetic mRNA to instruct cells to produce a protein that triggers an immune response.
+
+Toxoid Vaccines: These vaccines contain inactivated toxins produced by certain bacteria that cause disease. They are effective in immunizing against the disease by stimulating an immune response. Examples include the diphtheria and tetanus vaccines.
+
+Recommended Childhood Vaccination Schedule
+
+The Centers for Disease Control and Prevention (CDC) provides a recommended vaccination schedule for children in the United States. Key vaccines include:
+
+At Birth: Hepatitis B (1st dose)
+2 Months: DTaP (diphtheria, tetanus, pertussis), Hib, IPV (polio), PCV13 (pneumococcal), RV (rotavirus)
+4 Months: DTaP, Hib, IPV, PCV13, RV
+6 Months: DTaP, Hib, IPV, PCV13, RV, and Hepatitis B (2nd dose)
+12-15 Months: MMR, varicella, Hib, PCV13
+15-18 Months: DTaP (4th dose)
+4-6 Years: DTaP, IPV, MMR, varicella
+11-12 Years: Tdap (tetanus, diphtheria, pertussis), meningococcal, HPV
+16 Years: Meningococcal booster
+
+Effectiveness of Vaccines
+
+Vaccines are among the most effective public health tools, preventing millions of cases of disease every year. Herd immunity, achieved when a high percentage of the population is vaccinated, protects those who cannot be vaccinated, such as infants and individuals with certain health conditions.
+
+The World Health Organization (WHO) states that vaccine coverage of 95% or higher is required for the effective control of highly infectious diseases like measles. When vaccination rates drop, herd immunity is compromised, leading to outbreaks.
+
+Combatting Vaccine Myths and Misconceptions
+
+Despite the established benefits of vaccination, misinformation continues to fuel vaccine hesitancy. Common myths include:
+
+Vaccines cause autism: This misconception originated from a 1998 study that was later discredited and retracted. Extensive research has failed to find any link between vaccines and autism.
+
+Natural immunity is better: While natural immunity can be strong, it often comes at the risk of severe illness or complications. Vaccines offer a safer alternative to gaining immunity.
+
+Vaccines contain harmful substances: Vaccines may contain preservatives, adjuvants, and trace amounts of materials used in the manufacturing process, but these are present in quantities far below harmful levels and are necessary for vaccine effectiveness.
+
+Importance of Vaccination
+
+Vaccinating children not only protects them from severe illnesses but also reduces the burden on healthcare systems by minimizing the incidence of infectious diseases. Vaccination has led to significant declines in diseases such as:
+
+Measles: Prior to widespread vaccination, measles caused approximately 2.6 million deaths annually worldwide. Vaccination efforts have led to a dramatic decline in these numbers.
+
+Polio: Polio vaccination has brought the disease to the brink of eradication, with only a handful of cases remaining in certain parts of the world.
+
+Pertussis (Whooping Cough): Though still endemic, increased vaccination has led to a decrease in severe cases and complications.
+
+Global Vaccination Efforts
+
+In response to preventable diseases, global initiatives such as the Global Vaccine Action Plan (GVAP) aim to increase vaccination coverage in developing countries. The GAVI Alliance works strategically to ensure equitable access to vaccines, especially in low-income nations. These efforts have led to improvements in childhood vaccination rates worldwide.
+
+Conclusion
+
+Childhood vaccines are a cornerstone of public health, preventing countless cases of disease and saving lives. As vaccine development continues to advance, it is crucial to address misconceptions and educate the public about the safety and efficacy of vaccines. Continued commitment to vaccination will ensure that future generations can enjoy a healthier, disease-free life. Maintaining high vaccination rates is not only vital for individual protection but also for safeguarding public health and achieving herd immunity. As we strive to increase awareness and accessibility of vaccines globally, the collective aim remains clear: to eliminate preventable diseases and improve health outcomes for children everywhere.
+
+In conclusion, the legacy of childhood vaccines is one of success, resilience, and hope for a healthier future.
\ No newline at end of file